Legend Biotech Income Statement (2019-2025) | LEGN

Income Statement Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue (Quarter)
0.01B0.02B0.02B0.04B0.05B0.01B0.03B0.03B0.04B0.07B0.10B79.46B0.09B0.19B0.16B0.19B0.20B0.26B0.27B0.31B
Operating items
Research & Development (Quarter)
-0.00B-0.15B-0.07B-0.09B-0.08B-0.07B-0.10B-0.08B-0.08B-0.10B-0.10B-0.00B-0.10B-0.11B-0.10B-0.10B-0.10B-0.10B-0.11B-0.10B
Selling, General & Administrative (Quarter)
-0.00B-0.02B-0.01B-0.02B-0.01B-0.02B-0.02B-0.03B-0.02B-0.03B-0.03B-0.00B-0.03B-0.04B-0.04B-0.03B-0.03B-0.03B-0.03B-0.04B
Other Operating Expenses (Quarter)
0.00B-0.00B-0.00B
Operating Expenses (Quarter)
-0.00B-0.17B-0.08B-0.10B-0.09B-0.09B-0.13B-0.11B-0.11B-0.12B-0.12B-0.00B-0.13B-0.15B-0.13B-0.14B-0.13B-0.13B-0.15B-0.14B
Operating Income (Quarter)
-0.07B-0.08B-0.04B-0.02B
EBIT (Quarter)
-0.00B-0.17B-0.12B-0.09B-0.03B-0.19B-0.09B-0.14B-0.11B-0.20B-0.04B-0.15B-0.07B-0.02B-0.07B-0.08B-0.10B-0.13B-0.04B-0.02B
Non-operating items
Interest & Investment Income (Quarter)
0.01B0.02B0.02B0.01B0.01B0.01B0.01B0.01B
Other Non Operating Income (Quarter)
0.00B-0.01B-0.04B0.03B0.03B-0.07B0.06B-0.01B0.02B-0.01B-0.02B0.01B0.05B0.01B-0.06B0.11B0.06B-0.11B0.00B-0.00B
Net income details
EBT (Quarter)
-0.00B-0.17B-0.12B-0.09B-0.03B-0.19B-0.08B-0.14B-0.11B-0.20B-0.06B-0.15B-0.06B-0.02B-0.12B0.04B-0.10B-0.12B-0.04B-0.02B
Tax Provisions (Quarter)
0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B0.00B-0.00B-0.00B-0.00B-0.00B0.02B-0.00B-0.00B-0.00B
Profit After Tax (Quarter)
0.00B-0.17B-0.12B-0.08B0.00B0.00B-0.08B-0.14B-0.11B-0.20B-0.06B-0.00B-0.05B-0.02B-0.13B0.03B0.06B-0.13B-0.04B-0.03B
Income from Non-Controlling Interests (Quarter)
-0.08B0.08B0.00B-0.04B-0.18B0.22B0.01B-0.01B-0.02B-0.05B-0.01B0.06B0.06B0.12B
Income from Continuing Operations (Quarter)
-0.00B-0.17B-0.12B-0.08B-0.03B-0.19B-0.08B-0.14B-0.11B-0.20B-0.06B-0.15B-0.06B-0.02B-0.12B0.02B-0.10B-0.12B-0.04B-0.02B
Income from Discontinued Operations (Quarter)
-0.00B0.00B-0.01B-0.01B
Consolidated Net Income (Quarter)
-0.00B-0.17B-0.12B-0.08B-0.03B-0.19B-0.08B-0.14B-0.11B-0.20B-0.06B-0.15B-0.06B-0.02B-0.12B0.00B-0.10B-0.12B-0.04B-0.03B
Income towards Parent Company (Quarter)
-0.00B0.17B-0.12B-0.09B-0.03B-0.19B-0.08B-0.14B-0.11B-0.20B-0.06B-0.00B-0.06B-0.02B-0.13B0.00B-0.10B-0.12B-0.04B-0.03B
Net Income towards Common Stockholders (Quarter)
-0.00B0.17B-0.12B-0.09B-0.03B-0.19B-0.08B-0.14B-0.11B-0.20B-0.06B-0.09B-0.06B-0.02B-0.13B-0.06B-0.10B-0.12B-0.04B-0.03B
Additional items
EPS (Basic) (Quarter)
0.00273.93-0.43-0.31-0.10-0.62-0.26-0.43-0.34-0.57-0.17-0.25-0.16-0.05-0.34-0.16-0.27-0.34-0.10-0.08
EPS (Diluted) (Quarter)
0.000.62-0.43-0.30-0.10-0.62-0.26-0.43-0.34-0.57-0.17-0.25-0.16-0.05-0.34-0.16-0.27-0.34-0.10-0.08
Shares Outstanding (Quarter)
0.27B0.00B0.29B0.28B0.31B0.31B0.32B0.32B0.33B0.35B0.36B0.35B0.36B0.37B0.37B0.37B0.37B0.37B0.37B0.37B
Shares Outstanding (Diluted) (Quarter)
0.27B0.28B0.29B0.29B0.31B0.31B0.32B0.32B0.33B0.35B0.36B0.35B0.36B0.37B0.37B0.37B0.37B0.37B0.37B0.37B
EBITDA (Quarter)
-0.00B-0.17B-0.12B-0.09B-0.03B-0.19B-0.09B-0.14B-0.11B-0.20B-0.04B-0.15B-0.07B-0.02B-0.07B-0.08B-0.10B-0.13B-0.04B-0.02B
Interest Expenses (Quarter)
0.00B-0.00B-0.00B-0.00B-0.00B0.00B-0.01B-0.00B0.01B-0.01B0.03B-0.00B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B-0.01B
Tax Rate (Quarter)
-4.31%0.00%4.09%0.51%0.08%0.11%0.15%-0.46%1.21%0.01%1.26%3.67%58.03%1.80%0.47%1.58%